If the only consequence of the fusion is constitutive TAZ-mediated transcription, then TAZ activation should be sufficient to promote EHE and the fusion should occur in other cancers where TAZ activation promotes tumorigenesis. The gene discussed is WWTR1; the disease is cancer.